General Description
Amodiaquine hydrochloride 200mg film coated tablets equivalent to
Amodiaquine 153mg base & Artesunate 50mg tablets, Co blister of
6+6/PAC-10
Technical specifications
Each film coated tablet contains Amodiaquine Hydrochloride 200mg,
equivalent to Amodiaquine 153mg base.
Each tablet contains Artesunate 50mg. Ph.Int.
Both tablets should be scored with at least one break line to allow for
division of tablets into two parts, each containing the same amount of
active ingredients.
Therapeutic class
Amodiaquine is a 4-Aminoquinolone
Artesunate is an artemesinin derivative
Standard shelf life
3 years (36 months)
Other available formulations
AQ 153mg& AS 50mg Co-blister 3+3, 6+6
AQ 75mg & AS 25mg Co-blister 6+6
AQ 150mg & AS 50mg Co-blister 3+3, 6+6
AQ 153mg+AS 50mg Fixed dose combination bilayered tablets, 3s, 6s, 12s
AQ 67.5mg+AS 25mg Fixed dose combination bilayered tablets, 3s
AQ 135mg+AS 50mg Fixed dose combination bilayered tablets, 3s
AQ 270mg+AS 100mg Fixed dose combination bilayered tablets, 3s, 6s
AQ 306.2mg+ AS 100mg Fixed dose combination tablets 3s, 6s
Indications
Treatment of uncomplicated malaria: By Mouth (PO)
Storage
Do not store above 30°C (86°F).
Keep out of the reach and sight of children
Dispensing instructions
Dispense in original container. Do not repack.
Both Amodiaquine and Artesunate must be taken in combination with each
other.
Guidelines for use
For more details, please see
World Health Organisation (WHO), Guidelines for the treatment of
Malaria: (www.who.int/malaria/en/)
WHO, Model Lists of Essential Medicines for adults and/or children
respectively:
(www.who.int/medicines/publications/essentialmedicines/en/index.html)
WHO Model Formulary: (apps.who.int/emlib/Default.aspx?Language=EN)
or your regional and/or national guidelines.
to top
|